Research - Oss, North Brabant, Netherlands
ModiQuest B.V. develops novel therapeutics for Rheumatoid Arthritis, and other inflammatory diseases, using recombinant antibody technology.ModiQuest B.V. is activily looking for partners to co-develop or outlicense several therapeutic leads for Rheumatoid Arthritis.Current leads: -anti inflammatory fully human antibody family-family of anti inflammatory peptides
Apache
Microsoft Office 365